Kuehl's CIRM Bill Advances on 9-0 Vote
Despite opposition from the California stem cell agency, a state Senate committee Wednesday approved legislation aimed at ensuring that the state receives both an economic and health-related return on its $3 billion stem cell research effort.
CIRM opposed the measure – SB771 – on the grounds that it was premature. However, the Health Committee sent the …
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.